Jacobson Pharma (HKG:2633) and JBM (Healthcare) (HKG:2161) renewed logistics and manufacturing services agreements for three years from April 1, 2026, to March 31, 2029, according to a March 6 joint Hong Kong bourse filing.
Under the agreements, the Jacobson group will continue providing logistics services to the JBM group, while the JBM group will provide manufacturing services for certain generic drugs to Jacobson.
Annual caps for the logistics services are set at HK$8 million for the year ending March 2027, HK$9 million for 2028, and HK$10 million for 2029.
Caps for the manufacturing services are HK$7 million, HK$8 million, and HK$9 million for the respective years, the filing said.
Comments